ERBB2 and breast carcinoma: Interestingly, overall levels of ANCO1 mRNA expression in different subtypes of breast cancer in the TCGA and Metabric datasets [16,17] showed significantly higher ANCO1 levels in TNBC (ER-, PR-, and HER2-) patient samples compared to other subtypes (Figure S1A).